|
|
Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection
Amandine Landemaine
,
Antoine Petitcollin
,
Charlène Brochard
,
Céline Miard
,
Marie Dewitte
et al.
Journal articles
hal-02533415v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A simple clinical and biological score to promote and enhance Ferroportine disease screening.
Amandine Landemaine
,
Houda Hamdi-Roze
,
Véronique Loustaud-Ratti
,
Xavier Causse
,
Bernard Drenou
et al.
Hepatology, 2017, 66, pp.430A-431A
Journal articles
hal-01671423v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Anal Fistulas in Severe Perineal Crohn's Disease Mri Assessment in the Determination of Long-Term Healing Rates
Charlène Brochard
,
Amandine Landemaine
,
Alexandre Merlini L'Heritier
,
Marie Provost Dewitte
,
Belinda Tchoundjeu
et al.
Journal articles
hal-01807749v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A simple clinical score to promote and enhance ferroportin disease screening
Amandine Landemaine
,
Houda Hamdi-Roze
,
Séverine Cunat
,
Véronique Loustaud-Ratti
,
Xavier Causse
et al.
Journal articles
hal-03467768v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease the value of a strategy based on therapeutic drug monitoring
Camille Lucidarme
,
Antoine Petitcollin
,
Charlène Brochard
,
Laurent Siproudhis
,
Marie Dewitte
et al.
Journal articles
hal-01998041v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|